Showing results (81-90 of 160) with videos related to

Sort By:
Pageof 16
Oncotarget|May 31, 2022
NF-κB over-activation portends improved outcomes in HPV-associated head and neck cancerTravis P Schrank, Andrew C Prince, Tejas Sathe, et al.
Future Oncology (London, England)|February 17, 2022
Xevinapant or placebo plus chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck: TrilynX phase III study designJean Bourhis, Barbara Burtness, Lisa F Licitra, et al.
Oral Oncology|March 31, 2019
PTEN loss is associated with resistance to cetuximab in patients with head and neck squamous cell carcinomaNnamdi Eze, Ju-Whei Lee, Dong-Hua Yang, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 21, 2007
Phosphorylation of Akt (Ser473) predicts poor clinical outcome in oropharyngeal squamous cell cancerZiwei Yu, Paul M Weinberger, Clarence Sasaki, et al.
Head & Neck|October 12, 2013
p16 status, pathologic and clinical characteristics, biomolecular signature, and long-term outcomes in head and neck squamous cell carcinomas of unknown primaryLanea M Keller, Thomas J Galloway, Thomas Holdbrook, et al.
Cancer Journal (Sudbury, Mass.)|September 1, 2007
Phase II trial of weekly docetaxel/irinotecan combination in advanced pancreatic cancerBarbara Burtness, Laurie Thomas, Rebecca Sipples, et al.
Cancer Research Communications|April 14, 2023
Digital Spatial Profiling Links Beta-2-microglobulin Expression with Immune Checkpoint Blockade Outcomes in Head and Neck Squamous Cell CarcinomaNiki Gavrielatou, Ioannis Vathiotis, Thazin Nwe Aung, et al.
Head & Neck|April 1, 2025
Phase II Trial of Chemotherapy, Cetuximab, and Erlotinib in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and NeckAarti Bhatia, Ranee Mehra, Jessica Bauman, et al.
American Journal of Clinical Oncology|November 11, 2010
Increased recurrences using intensity-modulated radiation therapy in the postoperative settingAruna Turaka, Tianyu Li, Navesh K Sharma, et al.
Oncotarget|August 13, 2015
Phospho-T356RB1 predicts survival in HPV-negative squamous cell carcinoma of the head and neckTim N Beck, John Kaczmar, Elizabeth Handorf, et al.
Pageof 16